PRTEE is a 15-item questionnaire designed to measure the forearm pain and disability in patients with LE. PRTEE allows patients to rate their levels of elbow pain and disability from 0 to 10. Test consists of 2 subscales: 1) Pain subscale \[5 items\] (0 = no pain, 10 = worst imaginable) 2) Function subscale \[Specific activities - 6 items, Usual activities - 4 items\] (0 = no difficulty, 10 = unable to do). A total score can be computed on a scale of 100 (0 = no disability).
Baseline
Group
Value
95% CI
Kinesiotaping
49
43.88 – 73
Sham Taping
53.75
48.62 – 63
Control
49.25
41 – 57.5
After Treatment
Group
Value
95% CI
Kinesiotaping
26.5
16.87 – 39.75
Sham Taping
50.25
42 – 58.37
Control
46.25
37.5 – 54.12
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
29.25
16.37 – 29.25
Sham Taping
47.5
41.37 – 61.37
Control
44.5
38.87 – 53.62
The Disabilities of the Arm, Shoulder and Hand Score (QuickDash)Secondary· 0. week (Baseline), 2. week (After Treatment), 6. week (4 weeks After Treatment)
The patients will be requested to score from 1 to 5 points any difficulty experienced during different daily activities related to the upper extremity. Test has 1 module of compulsory items and two optional modules: work module (4 items) and sport/performing arts module (4 items). Scores range from 0 to 100, where higher scores indicate more disability.
Baseline
Group
Value
95% CI
Kinesiotaping
50
41.5 – 74.43
Sham Taping
46.57
38.6 – 62.49
Control
46.59
33.81 – 57.39
After Treatment
Group
Value
95% CI
Kinesiotaping
29.5
10.4 – 59.7
Sham Taping
47.72
38.04 – 53.97
Control
39.77
33.52 – 49.42
4 weeks After Treatmentt
Group
Value
95% CI
Kinesiotaping
18.18
4.55 – 34.1
Sham Taping
47.72
34.62 – 56.81
Control
39.75
31.81 – 46.59
Visual Analogue Scale (VAS) at RestSecondary· 0. week (Baseline), Immediate Effect (right after first taping in KT and sham taping groups), 2. week (After Treatment) and 6. week (4 weeks After Treatment)
Pain on lateral epicondyle at rest during the day was evaluated with the visual analog scale (VAS 0-10 cm). Higher score indicates more pain.
Baseline
Group
Value
95% CI
Kinesiotaping
1.5
0 – 3.25
Sham Taping
1.5
0 – 3.25
Control
3
0 – 4
Immediate Effect
Group
Value
95% CI
Kinesiotaping
0
0 – 0.5
Sham Taping
1.5
0 – 3.25
Control
NA
NA – NA
After Treatment
Group
Value
95% CI
Kinesiotaping
0
0 – 0.25
Sham Taping
0.5
0 – 3
Control
1
0 – 3.5
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
0
0 – 0
Sham Taping
1
0 – 3.25
Control
1.5
0.75 – 3
Visual Analogue Scale (VAS) at Daily ActivitySecondary· 0. week (Baseline), Immediate Effect (right after first taping in KT and sham taping groups), 2. week (After Treatment) and 6. week (4 weeks After Treatment)
Pain on lateral epicondyle during daily activity was evaluated with the visual analog scale (VAS 0-10 cm). Higher score indicates more pain.
Baseline
Group
Value
95% CI
Kinesiotaping
6.5
5 – 7.25
Sham Taping
7.5
6.75 – 8
Control
7
5 – 7
Immediate Effect
Group
Value
95% CI
Kinesiotaping
5
1.5 – 6.25
Sham Taping
7
6 – 8
Control
NA
NA – NA
After Treatment
Group
Value
95% CI
Kinesiotaping
3
2 – 5
Sham Taping
7
5.75 – 8
Control
5
5 – 7
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
3
1.75 – 5.25
Sham Taping
6.5
4.75 – 7.25
Control
5.5
5 – 7
Visual Analogue Scale (VAS) at NightSecondary· 0. week (Baseline), 2. week (After Treatment), 6. week (4 weeks After Treatment)
Pain on lateral epicondyle at night was evaluated with the visual analog scale (VAS 0-10 cm). Higher score indicates more pain.
Before Treatment
Group
Value
95% CI
Kinesiotaping
2.5
0 – 4.5
Sham Taping
2.5
0 – 3.5
Control
3.5
0 – 5.75
After Treatment
Group
Value
95% CI
Kinesiotaping
0
0 – 0.25
Sham Taping
2
0 – 3.5
Control
1
0 – 3.25
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
0
0 – 0
Sham Taping
2
0 – 3.25
Control
0
0 – 3.25
Painless Grip StrengthSecondary· 0. week (Baseline), Immediate Effect (right after first taping in KT and sham taping groups), 2. week (After Treatment) and 6. week (4 weeks After Treatment)
Grip strength will be measured using a hand held dynamometer (JAMAR, Sammons Preston, Inc., Bolingbrook, IL). Patients will be asked to grip the dynamometer until (s)he feel pain in elbow. Three evaluations will be made with resting periods in between and average scores will be recorded.
Baseline
Group
Value
95% CI
Kinesiotaping
14
8 – 19.75
Sham Taping
12
2 – 25
Control
13
9.5 – 20.5
Immediate Effect
Group
Value
95% CI
Kinesiotaping
17
10 – 23
Sham Taping
13
3.75 – 27.75
Control
NA
NA – NA
After Treatment
Group
Value
95% CI
Kinesiotaping
17.5
14.75 – 28.25
Sham Taping
13
10 – 21.25
Control
15
9.5 – 20.5
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
20
17 – 28.75
Sham Taping
14.5
10 – 24.5
Control
14.5
9.5 – 20.5
Grip StrengthSecondary· 0. week (Baseline), Immediate Effect (right after first taping in KT and sham taping groups), 2. week (After Treatment) and 6. week (4 weeks After Treatment)
Grip strength will be measured using a hand held dynamometer (JAMAR, Sammons Preston, Inc., Bolingbrook, IL). Patients will be asked to grip with maximum strength. Three evaluations will be made with resting periods in between and average scores will be recorded.
Baseline
Group
Value
95% CI
Kinesiotaping
20
14.75 – 27.5
Sham Taping
19.5
14.75 – 30.25
Control
23.5
15 – 28.25
Immediate Effect
Group
Value
95% CI
Kinesiotaping
22
16.5 – 29.25
Sham Taping
19.5
14.5 – 32.5
Control
NA
NA – NA
After Treatment
Group
Value
95% CI
Kinesiotaping
22.5
17.5 – 29.25
Sham Taping
20
14.5 – 27.25
Control
24
19 – 25.75
4 weeks After Treatment
Group
Value
95% CI
Kinesiotaping
25
21.5 – 28.75
Sham Taping
21
12 – 28
Control
24
18.5 – 27
Adverse events — posted to ClinicalTrials.gov
Time frame: 6 weeks.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The aim of this study is to compare the effects of kinesiology taping with exercise, sham taping with exercise and exercise alone for lateral epicondylitis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07364591 — Immediate Effect of Kinesiotaping With Rounded Shoulder Posture in University Students
· NA
· not yet recruiting
NCT07330115 — Combination of Kinesio Tape and Proprioceptive Neck Exercises on Proprioception in Patients With Cervical Radiculopathy
· NA
· not yet recruiting
NCT07098962 — KinesioTaping for Thoracic Drain Support
· Phase 2, PHASE3
· completed
NCT06977321 — Effectiveness of Kinesiotaping and Peloidotherapy in Carpal Tunnel Syndrome
· NA
· recruiting
NCT06981715 — Investigation of the Efficacy of Extracorporeal Shock Wave Therapy and Kinesiotaping Applied as an Addition to Conservat
· NA
· completed
Other recruiting trials for Lateral Epicondylitis
Currently open trials in the same condition.
NCT07424794 — Mobilization With Movement Verses Cyriax Techniques Among Athletes With Lateral Epicondylitis
· NA
· recruiting
NCT07365033 — Eccentric Exercise With Blood Flow Restriction vs Resistance Training for Lateral Epicondylitis
· NA
· recruiting
NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis
· Phase 4
· recruiting
NCT07410663 — Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis
· active not recruiting
NCT07314840 — Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis
· recruiting
Other Marmara University trials
Trials by the same sponsor.
NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke
· NA
· not yet recruiting
NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students
· NA
· not yet recruiting
NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery
· NA
· not yet recruiting
NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke
· recruiting
NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marmara University
Last refreshed: 3 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03074500.